Table 1 Antibiotics susceptibility testing of target strains
From: Characterization of blaAFM-1-positive carbapenem-resistant strains isolated in Guangzhou, China
Antibiotics | AN70 MIC (µg/ml) | NFYY023 MIC | E202 MIC | NCTC10498 MIC | ||||
|---|---|---|---|---|---|---|---|---|
Amikacin | > 32 | R | > 32 | R | < = 8 | S | 16 | R |
Gentamicin | > 8 | R | > 8 | R | > 8 | R | 8 | R |
Imipenem | > 8 | R | > 8 | R | > 8 | R | > 8 | R |
Meropenem | > 8 | R | > 8 | R | > 8 | R | > 8 | R |
Cefazolin | > 16 | – | > 16 | – | > 16 | – | > 16 | R |
Ceftazidime | > 16 | R | > 16 | R | > 16 | R | > 16 | R |
Cefotaxime | > 32 | R | > 32 | R | > 32 | R | > 32 | R |
Cefepime | > 16 | R | > 16 | R | > 16 | R | > 16 | – |
Ampicillin | > 16 | – | > 16 | – | > 16 | – | > 16 | R |
Piperacillin | > 64 | R | 64 | I | 64 | I | > 64 | R |
Amoxicillin-Clavulanate | > 16/8 | R | 8/4 | R | > 16/8 | R | > 16/8 | R |
Ampicillin-Sulbactam | > 16/8 | R | > 16/8 | – | > 16/8 | – | > 16/8 | R |
Piperacillin-Tazobactam | > 64/4 | R | 64/4 | I | 64/4 | I | > 64/4 | R |
Trimethoprim-Sulfamethoxazole | > 2/38 | R | > 2/38 | R | > 2/38 | R | 2/38 | S |
Chloramphenicol | > 16 | R | > 16 | R | > 16 | R | 16 | I |
Ciprofloxacin | > 2 | R | > 2 | R | > 2 | – | > 2 | – |
Levofloxacin | > 8 | R | > 8 | R | > 8 | R | > 8 | R |
Moxifloxacin | > 4 | – | > 4 | – | > 4 | – | > 4 | – |
Tetracycline | > 8 | R | > 8 | R | > 8 | R | > 8 | R |